Commonwealth Equity Services’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-70,956
Closed -$432K 3797
2021
Q3
$432K Sell
70,956
-2,229
-3% -$13.6K ﹤0.01% 2583
2021
Q2
$602K Buy
73,185
+5,229
+8% +$43K ﹤0.01% 2325
2021
Q1
$608K Sell
67,956
-4,060
-6% -$36.3K ﹤0.01% 2170
2020
Q4
$831K Buy
72,016
+460
+0.6% +$5.31K ﹤0.01% 1783
2020
Q3
$744K Hold
71,556
﹤0.01% 1683
2020
Q2
$940K Buy
71,556
+10,256
+17% +$135K ﹤0.01% 1459
2020
Q1
$482K Buy
61,300
+4,130
+7% +$32.5K ﹤0.01% 1720
2019
Q4
$1.18M Hold
57,170
﹤0.01% 1317
2019
Q3
$783K Buy
57,170
+5,697
+11% +$78K ﹤0.01% 1515
2019
Q2
$633K Buy
51,473
+4,312
+9% +$53K ﹤0.01% 1637
2019
Q1
$588K Buy
47,161
+4,796
+11% +$59.8K ﹤0.01% 1636
2018
Q4
$479K Buy
42,365
+4,000
+10% +$45.2K ﹤0.01% 1676
2018
Q3
$717K Buy
38,365
+10,000
+35% +$187K ﹤0.01% 1530
2018
Q2
$733K Sell
28,365
-400
-1% -$10.3K ﹤0.01% 1483
2018
Q1
$644K Sell
28,765
-202
-0.7% -$4.52K ﹤0.01% 1531
2017
Q4
$725K Buy
28,967
+402
+1% +$10.1K ﹤0.01% 1422
2017
Q3
$691K Hold
28,565
﹤0.01% 1399
2017
Q2
$578K Buy
28,565
+5,925
+26% +$120K ﹤0.01% 1477
2017
Q1
$609K Buy
22,640
+1,300
+6% +$35K ﹤0.01% 1393
2016
Q4
$406K Buy
21,340
+5,920
+38% +$113K ﹤0.01% 1536
2016
Q3
$301K Sell
15,420
-1,347
-8% -$26.3K ﹤0.01% 1721
2016
Q2
$251K Buy
+16,767
New +$251K ﹤0.01% 1793